Stocks
Health Care
vrtx
Vertex Pharmaceuticals
NASDAQ: VRTX
-1.10 (-0.26%)
421.53
USD
At close at Oct 24, 20:35 UTC
Income Statement
Revenue
11.02B
Gross Profit
9.49B
Operating Income
-233.40M
Pretax Income
4.37B
Net Income
-535.60M
EBITDA
486.30M
EBIT
279.10M
Earnings Per Share
-2.0800000000000005
Balance Sheet
Cash & Cash Equivalents
5.89B
Total Debt
1.25B
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
16.34B
Book Value Per Share
63.34
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.